hydroxyindoleacetic acid has been researched along with Cancer of Pancreas in 40 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urinary 5-hydroxyindoleacetic acid (5-HIAA) is an established biomarker in neuroendocrine tumors and carcinoid syndrome; however, its role in nonfunctional neuroendocrine tumors is not defined." | 9.30 | Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. ( Fisher, GA; Liyanage, N; Mirakhur, B; Pavel, ME; Phan, AT; Pitman Lowenthal, S; Vinik, AI; Wolin, EM, 2019) |
| "To assess whether serum histamine, chromogranin A or serotonin and urinary N-methylimidazoleacetic acid or 5-hydroxyindoleacetic acid correlate with advanced enterochromaffin cell changes or gastric carcinoids in patients with gastrinomas." | 7.71 | Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. ( Asgharian, B; Bashir, S; Bordi, C; Crafa, P; Entsuah, LK; Ferraro, G; Gibril, F; Jensen, RT; Ojeaburu, JV, 2002) |
| "A total of 13 patients with metastatic carcinoid tumour, paraganglioma, or unclassified "apudoma" were treated with single-agent carboplatin at a dose of 400 mg/m2 given by intravenous infusion every 4 weeks, on the basis that this new agent shows high activity against small-cell lung cancer that also has "apudoma" characteristics." | 7.68 | Carboplatin in the treatment of metastatic carcinoid tumours and paraganglioma: a phase II study. ( Jodrell, DI; Smith, IE, 1990) |
| "Urinary 5-hydroxyindoleacetic acid (5-HIAA) is an established biomarker in neuroendocrine tumors and carcinoid syndrome; however, its role in nonfunctional neuroendocrine tumors is not defined." | 5.30 | Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. ( Fisher, GA; Liyanage, N; Mirakhur, B; Pavel, ME; Phan, AT; Pitman Lowenthal, S; Vinik, AI; Wolin, EM, 2019) |
| "Patients with undifferentiated carcinomas, originating in typical neuroendocrine tumor sites (small and large bowel, pancreas, and stomach) or of unknown origin, who have consistent histologic findings by light microscopy should be evaluated for this possibility with appropriate immune staining or electron microscopy." | 5.28 | Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. ( Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J, 1991) |
| " Carcinoid tumors with liver metastases, especially those of midgut origin, produce serotonin via the precursors tryptophan and 5-hydroxytryptophan (5-HTP) and this overproduction contributes to the clinical symptoms of the carcinoid syndrome." | 5.07 | Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. ( Ahlström, H; Bergström, M; Eriksson, B; Långström, B; Lilja, A; Oberg, K, 1993) |
| "To assess whether serum histamine, chromogranin A or serotonin and urinary N-methylimidazoleacetic acid or 5-hydroxyindoleacetic acid correlate with advanced enterochromaffin cell changes or gastric carcinoids in patients with gastrinomas." | 3.71 | Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. ( Asgharian, B; Bashir, S; Bordi, C; Crafa, P; Entsuah, LK; Ferraro, G; Gibril, F; Jensen, RT; Ojeaburu, JV, 2002) |
| "A total of 13 patients with metastatic carcinoid tumour, paraganglioma, or unclassified "apudoma" were treated with single-agent carboplatin at a dose of 400 mg/m2 given by intravenous infusion every 4 weeks, on the basis that this new agent shows high activity against small-cell lung cancer that also has "apudoma" characteristics." | 3.68 | Carboplatin in the treatment of metastatic carcinoid tumours and paraganglioma: a phase II study. ( Jodrell, DI; Smith, IE, 1990) |
| " In this study we examined the effects of two agents that promote cellular differentiation, sodium butyrate and hexamethylene bisacetamide, on the in vitro growth and secretory responses of a human pancreatic carcinoid (BON) and human gastrinoma (PT-2 and PT-SM) cell lines that have been established in our laboratory." | 3.68 | Differential effects of sodium butyrate and hexamethylene bisacetamide on growth and secretion of cultured human endocrine tumor cells. ( Beauchamp, RD; Haber, BE; Hsieh, J; Ishizuka, J; Karp, G; Parekh, D; Rajaraman, S; Thompson, JC; Townsend, CM, 1991) |
| "Malignant carcinoid tumours, islet cell tumours and medullary carcinomas of the thyroid are tumours with similar clinical features." | 2.67 | Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers. ( Biesma, B; de Bruijn, HW; de Vries, EG; Kema, IP; Mulder, NH; Postmus, PE; Sleijfer, DT; Verschueren, RC; Willemse, PH, 1992) |
| "Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for other disorders initially." | 2.53 | Neuroendocrine Tumors. ( Basuroy, R; Ramage, JK; Srirajaskanthan, R, 2016) |
| "The diagnosis of a pancreatic carcinoid should be based on the measurement of serotonin in serum or its demonstration in the tumor and/or by the measurement of its derivative (5-HIAA) in urine." | 2.40 | Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature. ( Domenico, DR; el Attar, A; Howard, JM; Kim, K; Mao, C, 1998) |
| "Primary ovarian carcinoid tumors are rare neuroendocrine tumors, and can be associated with carcinoid syndrome and carcinoid heart disease." | 1.72 | A Case of Primary Insular Ovarian Carcinoid Tumor with Hyperandrogenism and Carcinoid Heart Disease. ( Al-Agha, R; Anaka, MR; Mansour, S, 2022) |
| "A prospective database of carcinoid patients seen at Duke University Medical Center was kept from 1970 to the present." | 1.31 | Gastrointestinal carcinoids: characterization by site of origin and hormone production. ( Feldman, JM; Hayward, TZ; Kirshbom, PM; Onaitis, MW; Quayle, FJ; Seigler, HF; Tyler, DS, 2000) |
| "35 pts with carcinoid tumors (group A--24 pts with metastatic disease, group B--11 pts after resection of the primary tumor with no metastases detected at the time of the investigation) were included into the study." | 1.31 | The occurrence of malignant carcinoid syndrome in patients with carcinoid tumors. ( Bulas, J; Duris, I; Jurkovicova, I; Kinova, S; Kovacova, E; Makaiova, I; Murin, J; Stenova, E, 2002) |
| "Gastrointestinal foregut carcinoids make up a small percentage (3% to 6%) of all reported carcinoids." | 1.30 | Foregut carcinoids: a clinical and biochemical analysis. ( Feldman, C; Feldman, JM; Hata, A; Kehoe, TE; Kherani, AR; Kirshbom, PM; Onaitis, MW; Tyler, DS, 1999) |
| "4/16 carcinoids and none out of 10 endocrine pancreatic tumours showed objective regression." | 1.28 | Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours. ( Bokemeyer, C; Poliwoda, H; Schmoll, E; Schmoll, HJ; Schöber, C; Schuppert, F; Stahl, M; Weiss, J; Wilke, H, 1992) |
| "Patients with undifferentiated carcinomas, originating in typical neuroendocrine tumor sites (small and large bowel, pancreas, and stomach) or of unknown origin, who have consistent histologic findings by light microscopy should be evaluated for this possibility with appropriate immune staining or electron microscopy." | 1.28 | Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. ( Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (25.00) | 18.7374 |
| 1990's | 13 (32.50) | 18.2507 |
| 2000's | 8 (20.00) | 29.6817 |
| 2010's | 8 (20.00) | 24.3611 |
| 2020's | 1 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Mansour, S | 1 |
| Anaka, MR | 1 |
| Al-Agha, R | 1 |
| Chan, DL | 1 |
| Dixon, M | 1 |
| Law, CHL | 1 |
| Koujanian, S | 1 |
| Beyfuss, KA | 1 |
| Singh, S | 1 |
| Myrehaug, S | 1 |
| Hallet, J | 1 |
| Tirosh, A | 1 |
| Nilubol, N | 2 |
| Patel, D | 1 |
| Kebebew, E | 2 |
| Pavel, ME | 1 |
| Phan, AT | 1 |
| Wolin, EM | 1 |
| Mirakhur, B | 1 |
| Liyanage, N | 1 |
| Pitman Lowenthal, S | 1 |
| Fisher, GA | 1 |
| Vinik, AI | 1 |
| Pinto, MP | 1 |
| Muñoz Medel, M | 1 |
| Carrillo, D | 1 |
| Retamal, IN | 1 |
| Bravo, ML | 1 |
| Valenzuela, Y | 1 |
| Nervi, B | 1 |
| Sánchez, C | 1 |
| Galindo, H | 1 |
| Ibañez, C | 1 |
| Peña, J | 1 |
| Balmaceda, C | 1 |
| Madrid, J | 1 |
| Briones, J | 1 |
| Torres, J | 1 |
| Nilo, F | 1 |
| Guarda, FJ | 1 |
| Quintana, JC | 1 |
| Orellana, P | 1 |
| Mondaca, S | 1 |
| Acevedo, F | 1 |
| Vicentini, D | 1 |
| Cordova-Delgado, M | 1 |
| Owen, GI | 1 |
| Garrido, M | 1 |
| Padelli, M | 1 |
| Bruno, C | 1 |
| Lemarchand, J | 1 |
| Vourc'h, P | 1 |
| Andres, C | 1 |
| Blasco, H | 1 |
| Benz-de Bretagne, I | 1 |
| Sadowski, SM | 1 |
| Neychev, V | 1 |
| Millo, C | 1 |
| Shih, J | 1 |
| Herscovitch, P | 1 |
| Pacak, K | 1 |
| Marx, SJ | 1 |
| Basuroy, R | 1 |
| Srirajaskanthan, R | 1 |
| Ramage, JK | 1 |
| Lenze, S | 1 |
| Aumann, V | 1 |
| Kluba, U | 1 |
| Wagemann, W | 1 |
| Evert, M | 1 |
| Mittler, U | 1 |
| Vorwerk, P | 1 |
| Berković, MC | 1 |
| Jokić, M | 1 |
| Marout, J | 1 |
| Radosević, S | 1 |
| Zjacić-Rotkvić, V | 1 |
| Kapitanović, S | 1 |
| Bashir, S | 1 |
| Gibril, F | 1 |
| Ojeaburu, JV | 1 |
| Asgharian, B | 1 |
| Entsuah, LK | 1 |
| Ferraro, G | 1 |
| Crafa, P | 1 |
| Bordi, C | 1 |
| Jensen, RT | 1 |
| SAYLE, BA | 1 |
| LANG, PA | 1 |
| GREEN, WO | 1 |
| BOSWORTH, WC | 1 |
| GREGORY, R | 1 |
| Arnold, R | 2 |
| Rinke, A | 1 |
| Klose, KJ | 2 |
| Müller, HH | 1 |
| Wied, M | 1 |
| Zamzow, K | 1 |
| Schmidt, C | 1 |
| Schade-Brittinger, C | 1 |
| Barth, P | 1 |
| Moll, R | 1 |
| Koller, M | 1 |
| Unterhalt, M | 1 |
| Hiddemann, W | 1 |
| Schmidt-Lauber, M | 1 |
| Pavel, M | 1 |
| Arnold, CN | 1 |
| Bläker, M | 1 |
| de Weerth, A | 1 |
| Formica, V | 1 |
| Wotherspoon, A | 1 |
| Cunningham, D | 1 |
| Norman, AR | 1 |
| Sirohi, B | 1 |
| Oates, J | 1 |
| Chong, G | 1 |
| Farmer, KL | 1 |
| Nold, R | 1 |
| Frank, M | 1 |
| Kajdan, U | 1 |
| Trost, U | 1 |
| Eriksson, B | 2 |
| Bergström, M | 1 |
| Lilja, A | 1 |
| Ahlström, H | 1 |
| Långström, B | 1 |
| Oberg, K | 1 |
| Pussard, E | 1 |
| Guigueno, N | 1 |
| Adam, O | 1 |
| Giudicelli, JF | 1 |
| Janson, ET | 1 |
| Bax, ND | 1 |
| Mignon, M | 1 |
| Morant, R | 1 |
| Opolon, P | 1 |
| Rougier, P | 1 |
| Oberg, KE | 1 |
| Mao, C | 1 |
| el Attar, A | 1 |
| Domenico, DR | 1 |
| Kim, K | 1 |
| Howard, JM | 1 |
| Kirshbom, PM | 2 |
| Kherani, AR | 1 |
| Onaitis, MW | 2 |
| Hata, A | 1 |
| Kehoe, TE | 1 |
| Feldman, C | 1 |
| Feldman, JM | 2 |
| Tyler, DS | 2 |
| Hayward, TZ | 1 |
| Quayle, FJ | 1 |
| Seigler, HF | 1 |
| Ricci, S | 1 |
| Antonuzzo, A | 1 |
| Galli, L | 1 |
| Ferdeghini, M | 1 |
| Bodei, L | 1 |
| Orlandini, C | 1 |
| Conte, PF | 1 |
| Kinova, S | 1 |
| Duris, I | 1 |
| Bulas, J | 1 |
| Murin, J | 1 |
| Kovacova, E | 1 |
| Stenova, E | 1 |
| Jurkovicova, I | 1 |
| Makaiova, I | 1 |
| Blanchin, M | 1 |
| James-Deidier, A | 1 |
| Chaumet-Riffaud, PD | 1 |
| Chayvialle, JA | 1 |
| Schöber, C | 1 |
| Schmoll, E | 1 |
| Schmoll, HJ | 1 |
| Poliwoda, H | 1 |
| Schuppert, F | 1 |
| Stahl, M | 1 |
| Bokemeyer, C | 1 |
| Wilke, H | 1 |
| Weiss, J | 1 |
| Biesma, B | 1 |
| Willemse, PH | 1 |
| Mulder, NH | 1 |
| Verschueren, RC | 1 |
| Kema, IP | 1 |
| de Bruijn, HW | 1 |
| Postmus, PE | 1 |
| Sleijfer, DT | 1 |
| de Vries, EG | 1 |
| Jodrell, DI | 1 |
| Smith, IE | 1 |
| Parekh, D | 1 |
| Ishizuka, J | 1 |
| Townsend, CM | 1 |
| Haber, BE | 1 |
| Beauchamp, RD | 1 |
| Rajaraman, S | 1 |
| Karp, G | 1 |
| Hsieh, J | 1 |
| Thompson, JC | 1 |
| Moertel, CG | 1 |
| Kvols, LK | 1 |
| O'Connell, MJ | 2 |
| Rubin, J | 1 |
| Varas Lorenzo, MV | 1 |
| Soga, J | 1 |
| Tazawa, K | 1 |
| Schwartz, MK | 1 |
| Patchefsky, AS | 2 |
| Solit, R | 1 |
| Phillips, LD | 1 |
| Craddock, M | 1 |
| Harrer, MV | 1 |
| Cohn, HE | 1 |
| Kowlessar, OD | 1 |
| Modlinger, RS | 1 |
| Nicolis, GL | 1 |
| Pertsemlidis, D | 1 |
| Gabrilove, JL | 1 |
| Gordon, G | 1 |
| Harrer, WV | 1 |
| Hoch, WS | 1 |
| Schein, PS | 1 |
| Blom, J | 1 |
| Hubbard, S | 1 |
| Magrath, IT | 1 |
| Bergevin, P | 1 |
| Wiernik, PH | 1 |
| Ziegler, JL | 1 |
| DeVita, VT | 1 |
| Gordon, DL | 1 |
| Lo, MC | 1 |
| Schwartz, MA | 1 |
| Jacobsson, L | 1 |
| Ottosson, JO | 1 |
4 reviews available for hydroxyindoleacetic acid and Cancer of Pancreas
| Article | Year |
|---|---|
Neuroendocrine Tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chromogranin A; Digestive System Surgical Pr | 2016 |
Additional tests of interest to the dermatologist.
Topics: alpha 1-Antitrypsin Deficiency; Angioedema; Complement C1 Inactivator Proteins; Erythema; Glucagon; | 1994 |
Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.
Topics: Adult; Aged; Carcinoid Tumor; Female; Humans; Hydroxyindoleacetic Acid; Pancreatic Neoplasms; Seroto | 1998 |
Biochemical procedures in different forms of cancer.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acid Phosphatase; Adrenal Gland Neoplasms; Alkaline Phos | 1971 |
8 trials available for hydroxyindoleacetic acid and Cancer of Pancreas
| Article | Year |
|---|---|
Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Chromogranin A; Female; Fo | 2019 |
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Chromogranin A; Chromogranins; Female; Germany; Huma | 2005 |
Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Carbon Radioisotopes; Carcinoid Tumor; Female; Gastrointes | 1993 |
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Biomarkers, | 1996 |
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoid Tumor; | 2000 |
[Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Female; France; Gastrinoma; Glucagonoma; Humans; Hydroxyindoleacetic | 1992 |
Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
Topics: Adenoma, Islet Cell; Adult; Aged; Apudoma; Biomarkers, Tumor; Blood Platelets; Carcinoid Tumor; Cate | 1992 |
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998).
Topics: Adenoma, Islet Cell; Blood Cells; Burkitt Lymphoma; Carcinoid Tumor; Carmustine; Clinical Trials as | 1974 |
28 other studies available for hydroxyindoleacetic acid and Cancer of Pancreas
| Article | Year |
|---|---|
A Case of Primary Insular Ovarian Carcinoid Tumor with Hyperandrogenism and Carcinoid Heart Disease.
Topics: Adult; Carcinoid Heart Disease; Carcinoid Tumor; Chromogranin A; Chromogranins; Female; Humans; Hydr | 2022 |
Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Topics: Aged; Cytoreduction Surgical Procedures; Embolization, Therapeutic; Female; Hepatectomy; Humans; Hyd | 2018 |
Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.
Topics: Adult; Aged; Disease Progression; Female; Humans; Hydroxyindoleacetic Acid; Intestinal Neoplasms; In | 2018 |
Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective.
Topics: Adult; Aged; Aged, 80 and over; Chile; Chromogranin A; Female; Humans; Hydroxyindoleacetic Acid; Inc | 2019 |
[Determination of thresholds values for platelet serotonin and urinary 5-HIAA concentrations for the biological diagnosis of digestive neuroendocrine tumors].
Topics: Adult; Aged; Biomarkers; Blood Chemical Analysis; Blood Platelets; Cohort Studies; Digestive System | 2019 |
Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Topics: Adult; Aged; Aged, 80 and over; Chromogranin A; Female; Humans; Hydroxyindoleacetic Acid; Intestinal | 2016 |
Unusual endocrine pancreatic carcinoma (carcinoid tumor) in a 14-year-old girl.
Topics: Adolescent; Biomarkers, Tumor; Carcinoid Tumor; Chromogranin A; Female; Humans; Hydroxyindoleacetic | 2008 |
IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).
Topics: Adult; Aged; Alleles; Biomarkers, Tumor; Cytokines; Female; Gastrointestinal Neoplasms; Genetic Pred | 2010 |
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoid Tumor; Chromogranin A; Chromogr | 2002 |
CUSHING'S SYNDROME DUE TO ISLET CELL CARCINOMA OF THE PANCREAS. REPORT OF TWO CASES: ONE WITH ELEVATED 5-HYDROXYINDOLE ACETIC ACID AND COMPLICATED BY ASPERGILLOSIS.
Topics: Acetates; Adenoma, Islet Cell; Adolescent; Adrenal Cortex Hormones; Adrenalectomy; Aspergillosis; Ca | 1965 |
[Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Chromogranin A; Chromogranins; Drug Combinations; Fe | 2006 |
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleace | 2007 |
[Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha].
Topics: Biomarkers, Tumor; Combined Modality Therapy; Female; Gastrinoma; Gastrins; Gastrointestinal Neoplas | 1994 |
Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine.
Topics: Adult; Aged; Anions; Blood Platelets; Borohydrides; Bronchial Neoplasms; Carcinoid Tumor; Cations; C | 1996 |
Foregut carcinoids: a clinical and biochemical analysis.
Topics: Adult; Age Distribution; Aged; Analysis of Variance; Carcinoid Tumor; Duodenal Neoplasms; Female; Ga | 1999 |
Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Topics: Carcinoid Tumor; Databases, Factual; Female; Gastrointestinal Neoplasms; Hormones, Ectopic; Humans; | 2000 |
The occurrence of malignant carcinoid syndrome in patients with carcinoid tumors.
Topics: Adult; Aged; Carcinoid Tumor; Female; Humans; Hydroxyindoleacetic Acid; Intestinal Neoplasms; Male; | 2002 |
Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.
Topics: Adult; Aged; Carcinoid Tumor; Drug Administration Schedule; Female; Humans; Hydroxyindoleacetic Acid | 1992 |
Carboplatin in the treatment of metastatic carcinoid tumours and paraganglioma: a phase II study.
Topics: Adult; Aged; Carboplatin; Carcinoid Tumor; Drug Administration Schedule; Drug Evaluation; Female; Hu | 1990 |
Differential effects of sodium butyrate and hexamethylene bisacetamide on growth and secretion of cultured human endocrine tumor cells.
Topics: 5-Hydroxytryptophan; Acetamides; Analysis of Variance; Butyrates; Butyric Acid; Carcinoid Tumor; Cel | 1991 |
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.
Topics: Adenoma, Islet Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; C | 1991 |
[Inhibition of pancreatic apudoma-dependent hypersecretion of gastrin, glucagon and serotonin using somatostatin-14].
Topics: Adult; Carcinoid Tumor; Female; Gastrins; Glucagon; Glucagonoma; Humans; Hydroxyindoleacetic Acid; M | 1987 |
Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases.
Topics: 5-Hydroxytryptophan; Carcinoid Tumor; Cytoplasmic Granules; Gastrointestinal Neoplasms; Histamine; H | 1971 |
Hydroxyindole-producing tumors of the pancreas. Carcinoid-islet cell tumor and oat cell carcinoma.
Topics: Adenoma, Islet Cell; Angiography; Biopsy; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyanosis; | 1972 |
Cushing's syndrome and avascular necrosis of bone associated with carcinoid-islet cell tumor of the pancreas.
Topics: Adenoma, Islet Cell; Adrenal Cortex Hormones; Adrenalectomy; Adult; Aged; Bone Diseases; Carcinoid T | 1972 |
Carcinoid tumor of the pancreas. Ultrastructural observations of a lymph node metastasis and comparison with bronchial carcinoid.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Aldosterone; Carcinoid Tumor; Carcinoma, Adenoid C | 1974 |
Carcinoid of the pancreas.
Topics: Adult; Carcinoid Tumor; Humans; Hydroxyindoleacetic Acid; Male; Pancreas; Pancreatic Neoplasms | 1971 |
Initial mental disorders in carcinoma of pancreas and stomach.
Topics: Adult; Aged; Anxiety; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; | 1971 |